台湾创投 · 2026 年 10 月第 2 周

生技产值8,301亿元,医疗新创募资件数与金额却双降

经济日报 · 2026-10-07

勤业众信陈重成指出,2025年台湾生技产业营收8,301亿元、年增7.05%,但健康医疗新创募资126件、6.6亿美元,件数与金额分别减11%、16%。获投新创年龄中位数升至5至6年,资金被AI与半导体吸走,新创须提早规划商业化。

Biotech revenue hits NT$830.1 billion, but health startup deals and funding both fall

Deloitte Taiwan's Chen Chung-cheng said Taiwan's biotech revenue reached NT$830.1 billion in 2025, up 7.05%, yet health startups closed 126 deals worth US$660 million, down 11% in count and 16% in value. The median age of funded firms rose to 5–6 years as AI and chips draw capital away, so startups must plan commercialization earlier.

阅读原文 ↗

← 回到本周观察